| Date | Time | Source | Headline | Symbol | Company |
| 09/20/2024 | 4:17PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AMIX | Autonomix Medical Inc |
| 09/20/2024 | 8:30AM | GlobeNewswire Inc. | Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum | NASDAQ:AMIX | Autonomix Medical Inc |
| 09/09/2024 | 7:00AM | GlobeNewswire Inc. | Autonomix Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients | NASDAQ:AMIX | Autonomix Medical Inc |
| 09/04/2024 | 6:27PM | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:AMIX | Autonomix Medical Inc |
| 08/27/2024 | 8:30AM | GlobeNewswire Inc. | Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference | NASDAQ:AMIX | Autonomix Medical Inc |
| 08/23/2024 | 5:00PM | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements | NASDAQ:AMIX | Autonomix Medical Inc |
| 08/21/2024 | 8:30AM | GlobeNewswire Inc. | Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress | NASDAQ:AMIX | Autonomix Medical Inc |
| 08/13/2024 | 5:00PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:AMIX | Autonomix Medical Inc |
| 08/13/2024 | 8:15AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AMIX | Autonomix Medical Inc |
| 08/13/2024 | 8:00AM | GlobeNewswire Inc. | Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones | NASDAQ:AMIX | Autonomix Medical Inc |
| 08/02/2024 | 8:30AM | GlobeNewswire Inc. | Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment | NASDAQ:AMIX | Autonomix Medical Inc |
| 07/26/2024 | 5:14PM | Edgar (US Regulatory) | Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] | NASDAQ:AMIX | Autonomix Medical Inc |
| 07/26/2024 | 4:06PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AMIX | Autonomix Medical Inc |
| 07/24/2024 | 8:00AM | GlobeNewswire Inc. | Autonomix Completes Licensing Transaction for FDA-Cleared Ablation Technology | NASDAQ:AMIX | Autonomix Medical Inc |
| 07/22/2024 | 9:05AM | GlobeNewswire Inc. | Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series | NASDAQ:AMIX | Autonomix Medical Inc |
| 07/18/2024 | 8:30AM | GlobeNewswire Inc. | Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Covering Technology License Agreement | NASDAQ:AMIX | Autonomix Medical Inc |
| 07/15/2024 | 8:00AM | GlobeNewswire Inc. | Autonomix Enters into Definitive Agreement to License Intellectual Property for FDA-Cleared Ablation Technology from RF Innovations, Inc. | NASDAQ:AMIX | Autonomix Medical Inc |
| 07/11/2024 | 9:00AM | GlobeNewswire Inc. | Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Launch of CEO Corner Platform | NASDAQ:AMIX | Autonomix Medical Inc |
| 07/03/2024 | 9:00AM | GlobeNewswire Inc. | Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment | NASDAQ:AMIX | Autonomix Medical Inc |
| 06/18/2024 | 8:05AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AMIX | Autonomix Medical Inc |
| 06/18/2024 | 8:00AM | GlobeNewswire Inc. | Autonomix Announces Positive Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial | NASDAQ:AMIX | Autonomix Medical Inc |
| 06/17/2024 | 5:14PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AMIX | Autonomix Medical Inc |
| 06/17/2024 | 4:05PM | GlobeNewswire Inc. | Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive Officer | NASDAQ:AMIX | Autonomix Medical Inc |
| 06/10/2024 | 8:00AM | GlobeNewswire Inc. | Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial on June 18, 2024 | NASDAQ:AMIX | Autonomix Medical Inc |
| 06/03/2024 | 8:15AM | GlobeNewswire Inc. | Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial | NASDAQ:AMIX | Autonomix Medical Inc |
| 05/31/2024 | 5:25PM | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:AMIX | Autonomix Medical Inc |
| 05/31/2024 | 4:56PM | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:AMIX | Autonomix Medical Inc |
| 05/31/2024 | 4:45PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AMIX | Autonomix Medical Inc |
| 05/31/2024 | 8:05AM | GlobeNewswire Inc. | Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update | NASDAQ:AMIX | Autonomix Medical Inc |
| 05/23/2024 | 9:15AM | GlobeNewswire Inc. | Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer | NASDAQ:AMIX | Autonomix Medical Inc |